FDA Eyes Indian Pharma to Plug US Ifosfamide Shortage

US regulators are in early talks with Cipla, Alkem and Zydus Lifesciences to boost supply of the cancer drug ifosfamide, reinforcing India's role as a critical backstop for US oncology shortages.

bt-corporate · 6/28/2026, 10:40:27 AM · Ask about this →